Articoli correlati a Sensitising cervix against cancer: Addition of gemcitabine...
Sensitising cervix against cancer: Addition of gemcitabine to standard therapy in locally advanced cervical cancer: A randomized comparative study - Brossura
Sinossi
The concurrent Chemoradiotherapy for cervical cancer treatment is well accepted since 1999. This study was aimed to observe if any improved outcome could be obtained capitalizing on the synergistic activity of Gemcitabine, Cisplatin, XRT. Stage IIB-IIIB were randomized to control group and study group. Control group received Cisplatin 40 mg/m2 weekly with concurrent XRT, followed by brachytherapy and study group received Gemcitabine 125 mg/m2 weekly top of the same control group treatment. The primary end-point was pathological response and toxicities along with patient compliance to treatment, late reactions, DFS & OS in a scenario like our local community. The complete response was slightly better in study arm. Toxicities were significantly high in the study group compared to control group. The distant failure prevailed in control arm. On a median follow up of little less than two years, the DFS in study arm was slightly better than control arm. If the toxicity can be managed adequately in the combination chemo radiation group, it may produce an improvement in response. Survival benefit can also be obtained by introducing gemcitabine to cisplatin as radio sensitizer.
Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.
L'autore
Dr. Sanjoy Roy has been trained in Radiation Oncology from C.N.C.I and is attached with the department since 2006. His area of interest is Cervical cancer and Breast conservation. Currently he is involved in Conformal Therapy delivery technique in Cervical Cancer and also delivers training & guidance to DNB PG trainees.
Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.
- EditoreLAP LAMBERT Academic Publishing
- Data di pubblicazione2012
- ISBN 10 3659146692
- ISBN 13 9783659146695
- RilegaturaCopertina flessibile
- Numero di pagine76
Compra nuovo
Scopri di più su questo articolo
EUR 47,14
Spese di spedizione:
EUR 3,58
In U.S.A.
I migliori risultati di ricerca su AbeBooks
Foto dell'editore
Sensitising cervix against cancer: Addition of gemcitabine to standard therapy in locally advanced cervical cancer: A randomized comparative study
Editore:
LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3659146692
ISBN 13: 9783659146695
Nuovo
Brossura
Da: Lucky's Textbooks, Dallas, TX, U.S.A.
Valutazione del venditore 5 su 5 stelle
Condizione: New. Codice articolo ABLIING23Mar3113020265995
Quantità: Più di 20 disponibili
Foto dell'editore
Sensitising cervix against cancer Addition of gemcitabine to standard therapy in locally advanced cervical cancer A randomized comparative study
Print on DemandDa: PBShop.store UK, Fairford, GLOS, Regno Unito
Valutazione del venditore 5 su 5 stelle
PAP. Condizione: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Codice articolo IQ-9783659146695
Quantità: 15 disponibili
Foto dell'editore
Sensitising cervix against cancer
Editore:
LAP Lambert Academic Publishing, 2012
ISBN 10: 3659146692
ISBN 13: 9783659146695
Nuovo
Brossura
Da: Ria Christie Collections, Uxbridge, Regno Unito
Valutazione del venditore 5 su 5 stelle
Condizione: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Codice articolo ria9783659146695_lsuk
Quantità: Più di 20 disponibili
Foto dell'editore
Sensitising cervix against cancer Addition of gemcitabine to standard therapy in locally advanced cervical cancer A randomized comparative study
Print on DemandDa: PBShop.store US, Wood Dale, IL, U.S.A.
Valutazione del venditore 5 su 5 stelle
PAP. Condizione: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Codice articolo L0-9783659146695
Quantità: Più di 20 disponibili
Foto dell'editore
Sensitising cervix against cancer
Editore:
LAP Lambert Academic Publishing 2012-06, 2012
ISBN 10: 3659146692
ISBN 13: 9783659146695
Nuovo
PF
Da: Chiron Media, Wallingford, Regno Unito
Valutazione del venditore 5 su 5 stelle
PF. Condizione: New. Codice articolo 6666-IUK-9783659146695
Quantità: 10 disponibili
Immagini fornite dal venditore
Sensitising cervix against cancer
Editore:
LAP Lambert Academic Publishing, 2012
ISBN 10: 3659146692
ISBN 13: 9783659146695
Nuovo
Taschenbuch
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
Valutazione del venditore 5 su 5 stelle
Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The concurrent Chemoradiotherapy for cervical cancer treatment is well accepted since 1999. This study was aimed to observe if any improved outcome could be obtained capitalizing on the synergistic activity of Gemcitabine, Cisplatin, XRT. Stage IIB-IIIB were randomized to control group and study group. Control group received Cisplatin 40 mg/m2 weekly with concurrent XRT, followed by brachytherapy and study group received Gemcitabine 125 mg/m2 weekly top of the same control group treatment. The primary end-point was pathological response and toxicities along with patient compliance to treatment, late reactions, DFS & OS in a scenario like our local community. The complete response was slightly better in study arm. Toxicities were significantly high in the study group compared to control group. The distant failure prevailed in control arm. On a median follow up of little less than two years, the DFS in study arm was slightly better than control arm. If the toxicity can be managed adequately in the combination chemo radiation group, it may produce an improvement in response. Survival benefit can also be obtained by introducing gemcitabine to cisplatin as radio sensitizer. 76 pp. Englisch. Codice articolo 9783659146695
Quantità: 2 disponibili
Immagini fornite dal venditore
Sensitising cervix against cancer : Addition of gemcitabine to standard therapy in locally advanced cervical cancer: A randomized comparative study
Editore:
LAP Lambert Academic Publishing, 2012
ISBN 10: 3659146692
ISBN 13: 9783659146695
Nuovo
Taschenbuch
Da: AHA-BUCH GmbH, Einbeck, Germania
Valutazione del venditore 5 su 5 stelle
Taschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The concurrent Chemoradiotherapy for cervical cancer treatment is well accepted since 1999. This study was aimed to observe if any improved outcome could be obtained capitalizing on the synergistic activity of Gemcitabine, Cisplatin, XRT. Stage IIB-IIIB were randomized to control group and study group. Control group received Cisplatin 40 mg/m2 weekly with concurrent XRT, followed by brachytherapy and study group received Gemcitabine 125 mg/m2 weekly top of the same control group treatment. The primary end-point was pathological response and toxicities along with patient compliance to treatment, late reactions, DFS & OS in a scenario like our local community. The complete response was slightly better in study arm. Toxicities were significantly high in the study group compared to control group. The distant failure prevailed in control arm. On a median follow up of little less than two years, the DFS in study arm was slightly better than control arm. If the toxicity can be managed adequately in the combination chemo radiation group, it may produce an improvement in response. Survival benefit can also be obtained by introducing gemcitabine to cisplatin as radio sensitizer. Codice articolo 9783659146695
Quantità: 2 disponibili
Immagini fornite dal venditore
Sensitising cervix against cancer
Editore:
LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3659146692
ISBN 13: 9783659146695
Nuovo
Kartoniert / Broschiert
Da: moluna, Greven, Germania
Valutazione del venditore 5 su 5 stelle
Kartoniert / Broschiert. Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Roy SanjoyDr. Sanjoy Roy has been trained in Radiation Oncology from C.N.C.I and is attached with the department since 2006. His area of interest is Cervical cancer and Breast conservation. Currently he is involved in Conformal Thera. Codice articolo 5134864
Quantità: Più di 20 disponibili
Foto dell'editore
Sensitising cervix against cancer: Addition of gemcitabine to standard therapy in locally advanced cervical cancer: A randomized comparative study
Editore:
LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3659146692
ISBN 13: 9783659146695
Antico o usato
Paperback
Da: Mispah books, Redhill, SURRE, Regno Unito
Valutazione del venditore 4 su 5 stelle
Paperback. Condizione: Like New. Like New. book. Codice articolo ERICA79636591466926
Quantità: 1 disponibili